CPV for Tablet Manufacturing: Weight, Hardness, Dissolution, and CU Trends







Published on 07/05/2026

Managing Continued Process Verification for Tablet Manufacturing: Addressing Weight, Hardness, Dissolution, and Control Unit Trends

In the realm of pharmaceutical tablet manufacturing, continued process verification (CPV) has emerged as a critical element for ensuring product consistency and quality over time. Variances in key quality attributes like weight, hardness, and dissolution rates can lead to significant commercial and regulatory challenges. This article addresses how to pinpoint potential issues early through a structured CPV program, equipping professionals with the tools to monitor performance effectively and maintain compliance.

By exploring symptoms and actionable solutions, readers will gain a practical understanding of how to utilize CPV data to detect process drift and uphold a validated state, thereby ensuring that tablet manufacturing meets GMP standards throughout its lifecycle.

Symptoms/Signals on the Floor or in the

Lab

The first step in any CPV initiative is recognizing the symptoms that may indicate underlying issues in the tablet manufacturing process. Key indicators include:

  • Weight Variability: Unexpected fluctuations in tablet weight can signal issues in material dosage or feeding systems.
  • Hardness Trends: Anomalies in tablet hardness testing results may suggest differences in formulation or compression parameters.
  • Dissolution Rate Changes: Variances from established dissolution profiles can hint at material degradation or changes in manufacturing conditions.
  • Control Unit Trends: Deviations in control charts for critical parameters can indicate a drift from the validated state.

These symptoms highlight areas where immediate action is warranted, setting the stage for deeper investigation and corrective measures to uphold quality.

Likely Causes (by category: Materials, Method, Machine, Man, Measurement, Environment)

Understanding the root causes of the observed symptoms is essential for effective problem-solving. Breakdowns can be categorized as follows:

  • Materials: Issues such as inconsistent raw material quality or changes in supplier specifications.
  • Method: Deviations in the manufacturing process, including changes in blending times or compression settings.
  • Machine: Equipment deterioration, uncalibrated instruments, or mechanical failure of critical components.
  • Man: Human error relating to operator training, adherence to protocols, or shifts in workforce.
  • Measurement: Inadequate measurement equipment or protocols can lead to erroneous data interpretation.
  • Environment: Factors like fluctuations in temperature and humidity affecting material properties during processing.

A comprehensive evaluation of these categories will allow for a targeted approach to identifying and mitigating issues impacting process validation.

Immediate Containment Actions (first 60 minutes)

Within the first hour of detecting a signal, it is critical to implement containment actions to prevent product nonconformance. Recommended steps include:

  1. Stop the Process: Immediately halt production to prevent further nonconforming product from being manufactured.
  2. Isolate Affected Batches: Set aside any batches that may have been produced under questionable conditions for further evaluation.
  3. Notify the Relevant Team: Inform quality assurance, production management, and regulatory teams of the situation.
  4. Conduct Initial Assessment: Quickly gather preliminary data on affected lots and any recent changes in process or materials.
  5. Review Control Charts: Analyze control charts for the affected attributes to assess whether the signal is a point or a trend.

These initial steps help clamp down on potential issues before they escalate, providing a clear path to move forward with investigation and corrective actions.

Investigation Workflow (data to collect + how to interpret)

Following containment actions, a structured investigation workflow is essential. This includes:

  1. Data Collection: Gather data on production parameters, raw material specifications, and recent changes to methods or equipment.
  2. Documentation Review: Check batch records, equipment logs, and operator notes for anomalies or deviations from standard procedures.
  3. Internal Communications: Hold a root cause investigation meeting with relevant personnel to discuss observations and gather insights.
  4. Statistical Analysis: Perform statistical analysis on the collected data to identify any significant trends or correlations.

Interpretation of the data will require looking for patterns over time, paying close attention to any correlations between the observed symptoms and potential causal factors that have risen during the investigation.

Root Cause Tools (5-Why, Fishbone, Fault Tree) and when to use which

To analyze root causes effectively, various tools can be employed:

  • 5-Why Analysis: This tool helps drill down through layers of causation. Start with the symptom and ask “why” repeatedly until the fundamental cause is identified.
  • Fishbone Diagram: Useful in visualizing potential causes in a structured manner across categories (Materials, Method, Environment, etc.). This is beneficial for brainstorming sessions.
  • Fault Tree Analysis: A deductive method used when the system is complex, allowing mapping of various paths to possible failures. Optimal for high-risk processes.

Selecting the appropriate tool depends on the complexity of the problem at hand and the available data. Often, employing multiple tools will yield comprehensive insights.

CAPA Strategy (correction, corrective action, preventive action)

Once a root cause has been established, developing a Corrective and Preventive Action (CAPA) strategy is crucial. This should be structured as follows:

  1. Correction: Take immediate action to correct the issue at hand. This could involve recalibrating equipment or replacing defective materials.
  2. Corrective Action: Identify and implement actions that will prevent the recurrence of the identified issue. This may include retraining operators or establishing tighter controls over material specifications.
  3. Preventive Action: Develop proactive measures to reduce the likelihood of future issues. This could consist of regular monitoring of key attributes with control charts or implementing changes to the CPV strategy.

Maintaining clear documentation of each step in the CAPA process is essential for regulatory inspections and compliance with both FDA and EMA standards.

Control Strategy & Monitoring (SPC/trending, sampling, alarms, verification)

An effective control strategy is imperative for sustaining product quality over time. Key components include:

  • Statistical Process Control (SPC): Utilize control charts to monitor key attributes like weight, hardness, and dissolution rates constantly. Establish control limits based on historical data, aiming for a Cpk value above 1.33.
  • Sampling Plans: Implement robust sampling techniques to routinely assess product quality and environmental conditions during production.
  • Automated Alarms: Employ alarms linked to critical parameter thresholds to trigger alerts for any deviations detected in real-time.
  • Regular Verification: Perform regular audits of the control strategy to ensure ongoing compliance and effectiveness.

Through careful implementation of these monitoring points, manufacturers can promptly detect any shifts in process performance and respond accordingly to maintain product quality.

Related Reads

Validation / Re-qualification / Change Control impact (when needed)

Any changes to the manufacturing process, based on insights gathered during CAPA and monitoring, may necessitate re-evaluation of validation and change control processes. Considerations include:

  • Validation Impact: Changes that affect an existing validated process must undergo re-validation to confirm that the adjustments do not negatively impact product quality.
  • Re-qualification: If significant changes are made to equipment or materials, re-qualification may be required to ensure these changes align with quality and regulatory expectations.
  • Change Control Processes: Implement a structured change control procedure to assess risk and ensure thorough review before any changes to processes or materials are approved.

Constant vigilance in reassessing these factors helps ensure ongoing compliance with regulatory standards and safeguards patient safety.

Inspection Readiness: what evidence to show (records, logs, batch docs, deviations)

Being inspection-ready is an ongoing responsibility within manufacturing environments. Key documentation and evidence required during inspections include:

  • Batch Records: Complete records that document every aspect of the manufacturing process, including production parameters and any deviations.
  • Equipment Logs: Detailed logs for all equipment in the manufacturing process to demonstrate maintenance and calibration history.
  • Deviation Reports: Comprehensive summaries of any deviations encountered during production along with the corresponding CAPA actions taken.
  • Control Charts: Historical data supporting the process control strategy, highlighting trends and any corrective actions implemented.

Maintaining clear, organized documentation is essential for compliance and helps demonstrate a commitment to quality during regulatory inspections.

FAQs

What is continued process verification (CPV)?

Continued process verification (CPV) is a systematic approach to monitoring and evaluating the performance of manufacturing processes after they have been validated to ensure consistent product quality.

How can I identify issues early in tablet manufacturing?

By implementing a structured CPV program that includes monitoring critical quality attributes through statistical process control, you can identify drift early on and take corrective actions promptly.

What tools are useful for root cause analysis?

Effective tools include 5-Why Analysis, Fishbone Diagrams, and Fault Tree Analysis which help identify the underlying causes of production issues.

How does CAPA function in CPV?

Corrective and Preventive Action (CAPA) is essential for responding to identified process issues, facilitating resolution of current problems and preventing their recurrence.

What is the importance of control charts in CPV?

Control charts help visualize the stability of key process parameters, allowing for the early detection of trends, enabling timely interventions.

What level of detail is required in batch records for inspections?

Batch records must include complete documentation of all processes, deviations, and corrective actions taken during production to show compliance with regulatory standards.

When should I re-qualify equipment in manufacturing processes?

Re-qualification should occur whenever there is a significant change in equipment, materials, or manufacturing processes that could affect product quality.

How do I ensure my CPV program is inspection-ready?

Maintain organized, comprehensive documentation of all CPV-related data, including control charts, deviation reports, and batch records to demonstrate quality compliance during inspections.

What are the regulatory expectations for CPV programs?

Regulatory expectations stipulate that manufacturers continuously monitor critical processes through CPV to ensure they remain within validated conditions, promoting high product quality and safety.

How do I collect data effectively for CPV analysis?

Collect data consistently through automated systems where possible, ensuring accurate and up-to-date information is recorded on key process parameters and quality attributes.

What is a CPV dashboard, and how can it help?

A CPV dashboard provides real-time visualization of key metrics, facilitating quick assessment of process performance and trends, enabling proactive decision-making.

Conclusion

Addressing challenges in tablet manufacturing through continued process verification enhances product quality and regulatory compliance. By being vigilant in monitoring, analyzing, and adjusting manufacturing processes based on robust data analysis, pharmaceutical professionals can preempt issues, thus paving the way for sustained success. Adopting a comprehensive CPV program and being inspection-ready are indispensable tools in maintaining control over manufacturing processes and ensuring that all tablets produced meet stringent quality standards.

Pharma Tip:  CPV Heat Maps for Multi-Site Pharmaceutical Manufacturing